FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151799520> ?p ?o ?g. }

• W2151799520 endingPage "185" @default.
• W2151799520 startingPage "176" @default.
• W2151799520 abstract "Despite advances in the treatment of nonsquamous non-small cell lung cancer (NSCLC), therapeutic choices and overall disease course for squamous NSCLC have remained relatively unchanged over the past several years. We provide a detailed account of current treatment patterns, healthcare use, and survival in real-world clinical settings for metastatic squamous NSCLC.Patients aged ≥65 years with metastatic squamous NSCLC diagnosed 2001-2009 were identified and followed through 2010 using the Surveillance, Epidemiology and End Results-Medicare database. Treatment patterns were descriptively analyzed. Multivariate logistic regressions were estimated to identify predictors of treatment pattern events; generalized linear models were estimated for total all-cause and NSCLC-related costs to assess cost drivers.Of 17,133 patients, 72% received cancer-directed therapy (surgery, radiation, chemotherapy, or biologic therapy), whereas 28% received only supportive care. Median survival was significantly longer in patients receiving cancer-directed therapy (8 months) than in patients receiving supportive care only (2 months) (P<0.0001). An agent-specific first-line chemotherapy regimen was identified for 91% of the 7700 patients who received chemotherapy. Among these, the most common first-line regimen was carboplatin-paclitaxel combination therapy (46%). Common second-line regimens were gemcitabine monotherapy (16%) and pemetrexed monotherapy (11%). Factors associated with decreased odds of receiving cancer-directed treatment were black versus white race (OR, 0.72; 95% CI, 0.64-0.82), residence in the West versus South (OR, 0.73; 95% CI, 0.66-0.81), and metastatic disease at initial diagnosis versus progression to metastatic disease (OR, 0.77; 95% CI, 0.70-0.84).Our study shows that prognosis remains poor for patients with metastatic squamous NSCLC, even among those receiving treatment, but particularly for patients limited to supportive care only, highlighting the continuing unmet medical need in this population. Additionally, our analysis indicates that selections for second-line and third-line chemotherapies are not necessarily consistent with National Comprehensive Cancer Network guidelines." @default.
• W2151799520 created "2016-06-24" @default.
• W2151799520 creator A5000505169 @default.
• W2151799520 creator A5003889471 @default.
• W2151799520 creator A5006797378 @default.
• W2151799520 creator A5027475930 @default.
• W2151799520 creator A5069970576 @default.
• W2151799520 creator A5070844863 @default.
• W2151799520 date "2015-02-01" @default.
• W2151799520 modified "2023-10-14" @default.
• W2151799520 title "Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer" @default.
• W2151799520 cites W119826808 @default.
• W2151799520 cites W1983521375 @default.
• W2151799520 cites W2005231101 @default.
• W2151799520 cites W2009671306 @default.
• W2151799520 cites W2018462333 @default.
• W2151799520 cites W2046317081 @default.
• W2151799520 cites W2050056063 @default.
• W2151799520 cites W2054340543 @default.
• W2151799520 cites W2057977761 @default.
• W2151799520 cites W2060629288 @default.
• W2151799520 cites W2072795086 @default.
• W2151799520 cites W2073543564 @default.
• W2151799520 cites W2083149063 @default.
• W2151799520 cites W2085811652 @default.
• W2151799520 cites W2093963297 @default.
• W2151799520 cites W2097124809 @default.
• W2151799520 cites W2098223916 @default.
• W2151799520 cites W2099725888 @default.
• W2151799520 cites W2104169491 @default.
• W2151799520 cites W2104701073 @default.
• W2151799520 cites W2110548428 @default.
• W2151799520 cites W2118522197 @default.
• W2151799520 cites W2123857987 @default.
• W2151799520 cites W2125289577 @default.
• W2151799520 cites W2128002599 @default.
• W2151799520 cites W2131664752 @default.
• W2151799520 cites W2151986118 @default.
• W2151799520 cites W2152905269 @default.
• W2151799520 cites W2166535194 @default.
• W2151799520 cites W2170680981 @default.
• W2151799520 cites W4252780045 @default.
• W2151799520 doi "https://doi.org/10.1016/j.lungcan.2014.11.002" @default.
• W2151799520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25532680" @default.
• W2151799520 hasPublicationYear "2015" @default.
• W2151799520 type Work @default.
• W2151799520 sameAs 2151799520 @default.
• W2151799520 citedByCount "50" @default.
• W2151799520 countsByYear W21517995202015 @default.
• W2151799520 countsByYear W21517995202016 @default.
• W2151799520 countsByYear W21517995202017 @default.
• W2151799520 countsByYear W21517995202018 @default.
• W2151799520 countsByYear W21517995202019 @default.
• W2151799520 countsByYear W21517995202020 @default.
• W2151799520 countsByYear W21517995202021 @default.
• W2151799520 countsByYear W21517995202022 @default.
• W2151799520 countsByYear W21517995202023 @default.
• W2151799520 crossrefType "journal-article" @default.
• W2151799520 hasAuthorship W2151799520A5000505169 @default.
• W2151799520 hasAuthorship W2151799520A5003889471 @default.
• W2151799520 hasAuthorship W2151799520A5006797378 @default.
• W2151799520 hasAuthorship W2151799520A5027475930 @default.
• W2151799520 hasAuthorship W2151799520A5069970576 @default.
• W2151799520 hasAuthorship W2151799520A5070844863 @default.
• W2151799520 hasConcept C121608353 @default.
• W2151799520 hasConcept C126322002 @default.
• W2151799520 hasConcept C143998085 @default.
• W2151799520 hasConcept C2776256026 @default.
• W2151799520 hasConcept C2776694085 @default.
• W2151799520 hasConcept C2777240266 @default.
• W2151799520 hasConcept C2778239845 @default.
• W2151799520 hasConcept C2780258809 @default.
• W2151799520 hasConcept C2781413609 @default.
• W2151799520 hasConcept C2781451048 @default.
• W2151799520 hasConcept C2908647359 @default.
• W2151799520 hasConcept C509974204 @default.
• W2151799520 hasConcept C71924100 @default.
• W2151799520 hasConcept C99454951 @default.
• W2151799520 hasConceptScore W2151799520C121608353 @default.
• W2151799520 hasConceptScore W2151799520C126322002 @default.
• W2151799520 hasConceptScore W2151799520C143998085 @default.
• W2151799520 hasConceptScore W2151799520C2776256026 @default.
• W2151799520 hasConceptScore W2151799520C2776694085 @default.
• W2151799520 hasConceptScore W2151799520C2777240266 @default.
• W2151799520 hasConceptScore W2151799520C2778239845 @default.
• W2151799520 hasConceptScore W2151799520C2780258809 @default.
• W2151799520 hasConceptScore W2151799520C2781413609 @default.
• W2151799520 hasConceptScore W2151799520C2781451048 @default.
• W2151799520 hasConceptScore W2151799520C2908647359 @default.
• W2151799520 hasConceptScore W2151799520C509974204 @default.
• W2151799520 hasConceptScore W2151799520C71924100 @default.
• W2151799520 hasConceptScore W2151799520C99454951 @default.
• W2151799520 hasIssue "2" @default.
• W2151799520 hasLocation W21517995201 @default.
• W2151799520 hasLocation W21517995202 @default.
• W2151799520 hasOpenAccess W2151799520 @default.
• W2151799520 hasPrimaryLocation W21517995201 @default.
• W2151799520 hasRelatedWork W1989051367 @default.

• next